Athersys Inc (ATHXQ)

[goupupup]

Website update ... SUMMARY

Multiple important objectives achieved ..

Launched the MACOVIA trial for COVID-19 induced ARDS and enrolled first patients ..

Launched the MATRICS-1 trial for trauma related inflammation and complications with UTHealth ..

Healios advancement of TREASURE trial (w/ Sakigakedesignation)..

Fast Track and RMAT designations granted by FDA for our Phase 3 Stroke program… Positive Scientific Advice from by EMA ..

Launch of (and continued enrollment in) MASTERS-2 trial ..

Expansion of contract manufacturing capabilities to include CMO sites in Europe and Japan ..

2018 Expansion of collaboration with Healios ..

Maintained healthy balance sheet; with recent financing of $57.6 million gross ..

Completion of enrollment in MUST-ARDS trial –and successful results ..

Fast Track and RMAT designation for ARDS program ..

Healios’ advancement of the ONE-BRIDGE study for ARDS and Orphan designation from PMDA ..

BARDA and CoronaWatch Task Force designation for MultiStem as a “Highly Relevant” therapeutic for COVID-19
Primary priorities for 2020 ..

Complete enrollment for TREASURE and ONE-BRIDGE studies (Healios trials in Japan ..

Advancement of MASTERS-2 Phase 3 program ..

Advancement of the Phase 2/3 pivotal MACOVIA trial..

Complete evaluation / implementation of key partnering initiatives ..

Continued advancement of key process development and manufacturing initiatives, & commercialization prep ..

Also GILLY BOY is going to get huge pressure from the institutional ownership after the nightmare of Hardy's public comments with Traub's recent departure, should be a big catalyst for the company GILLY BOY lacks execution ..GOOD LUCK LONGS

https://finance.yahoo.com/news/athersys-inc-nasdaq-athx-just-102003594.html